Topic: Novartis

Financial records reveal that Michael Cohen received millions of dollars from corporations including Novartis, AT&T, and Columbus Nova through his firm, Essential Consultants. While companies claimed they sought insight into the Trump administration, reports suggest Cohen was selling access he could not ultimately deliver. Special Counsel Robert Mueller has reportedly questioned these companies regarding the nature of the payments.

In a recorded Q&A, Craig Venter explains that synthetic genomics can produce flu vaccines in 24 hours and create new strains of algae to convert CO2 into fuel for ExxonMobil. The hosts remain skeptical, viewing these claims as a "solution to everything" designed to attract massive investment from pharmaceutical and energy companies.

The FDA is evaluating a new swine flu vaccine from Novartis that utilizes the adjuvant MF59. This development follows predictions that pharmaceutical companies would push for adjuvanted vaccines to stretch the supply of viral antigens and speed up the inoculation process.

The H1N1 "swine flu" vaccine rollout is beginning globally, with reports that UK doctors will be paid £5.25 per injection. In France, nurses are reportedly rejecting the vaccine due to safety concerns, a sentiment echoed by various medical practitioner groups worldwide. Novartis is moving forward with sales based on trials involving only 100 people, which the hosts characterize as a rushed and potentially dangerous process.

Baxter International and Novartis AG are highlighted as primary producers of vaccines and adjuvants, with institutional investors like Goldman Sachs holding significant shares. A recent appearance by Janet Napolitano on Real Time with Bill Maher is scrutinized, suggesting the media appearance was timed to normalize her presence before major government actions.

Pharmaceutical companies like Novartis are using experimental adjuvants such as MF59 in swine flu vaccines, despite a lack of long-term data on how they function. Health and Human Services Secretary Kathleen Sebelius signed a decree granting vaccine makers total immunity from liability for injuries caused by these shots. Critics argue the pandemic is being used as a loophole to conduct mass human testing of unapproved vaccine additives.

The US government committed nearly $1 billion to purchase H1N1 vaccine components, with the majority of funds going to Novartis for chemical adjuvants. Concerns have been raised that these "boosters" may overstimulate the immune system, potentially leading to an increase in Guillain-Barre syndrome cases.